Application: We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT1163 - DMAB-CPT1164
Summary
Specifications
Antibody Isotype
IgG
Clone
351468D9
Species Reactivity
Human
Immunogen
IKZF4 fusion protein
Conjugate
Unconjugated
Applications
Application Notes
We recommend the following antibodies for sandwich immunoassay (Capture - Detection): DMAB-CPT1163 - DMAB-CPT1164 Cytometric Bead Array: 0.625-40 ng/mL
General Notes
This product (Catalog No. DMAB-CPT1164) is a rabbit-derived monoclonal antibody raised against human IKZF4. It has been affinity purified by Protein A. IKZF4 is a member of the Ikaros family transcription factors. The Ikaros family was originally designated to function in hematopoiesis, but it is only recently that studies have begun to show the relevance of this family in T helper cell differentiation. IKZF3 was preferentially expressed in TH17 cells and governs TH17 differentiation by silencing IL-2 expression. By investigating the dynamics of the TH17 regulatory network, IKZF4 was proposed by Yosef et al. as a composite in the negative regulatory module for TH17. DMAB-CPT1164 is suitable for use in Cytometric Bead Array (0.625-40 ng/mL) application. DMAB-CPT1164 is supplied as a liquid formulation in PBS only. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
EOS; IKZF4; KIAA1782; Zinc finger protein Eos; ZNFN1A4; IKAROS family zinc finger 4 (Eos)
My Review for Magic™ Rabbit Anti-Human IKZF4 Monoclonal antibody, clone 351468D9
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.